Chen-chen P. Ren
Zhengzhou Key Laboratory Of Endometrial Disease Prevention And Treatment Zhengzhou China
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity.
Journal: Bioorganic chemistry
Published: June 05, 2025
Efficacy and Safety of the Chinese Herbal Compound TJAOA101 in Treating Diminished Ovarian Reserve: A Protocol for Multicenter, Prospective, and Pre-Post Study.
Journal: Current medical science
Published: December 05, 2022
A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer.
Journal: Frontiers in cell and developmental biology
Published: May 01, 2021
A Slug-dependent mechanism is responsible for tumor suppression of p53-stabilizing compound CP-31398 in p53-mutated endometrial carcinoma.
Journal: Journal of cellular physiology
Published: August 19, 2019
The relationship between simple numerical function and gray matter volume in normal brain aging
Journal: Zhonghua yi xue za zhi
Published: February 18, 2019
Neuropilin-1 is associated with the prognosis of cervical cancer in Henan Chinese population.
Journal: OncoTargets and therapy
Published: November 13, 2018
HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells.
Journal: Cancer cell international
Published: June 29, 2018
MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
Journal: International journal of oncology
Published: May 04, 2018
CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s.
Journal: Journal of cellular physiology
Published: March 09, 2018
CP‑31398 attenuates endometrial cancer cell invasion, metastasis and resistance to apoptosis by downregulating MDM2 expression.
Journal: International journal of oncology
Published: February 05, 2018
Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Journal: Journal of cellular physiology
Published: January 17, 2018
RNAi‑mediated downregulation of asparaginase‑like protein 1 inhibits growth and promotes apoptosis of human cervical cancer line SiHa.
Journal: Molecular medicine reports
Published: December 21, 2017
Last Updated: 09/26/2026